Status:
COMPLETED
Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases
Lead Sponsor:
Medical University of Graz
Conditions:
Myeloproliferative Disorder
Myelodysplastic Syndromes
Eligibility:
All Genders
18-95 years
Brief Summary
Myelodysplastic and myeloproliferative Disease represent conditions with increased risk for pulmonary hypertension. However, the exact prevalence of pulmonary hypertension in these conditions is not k...
Detailed Description
For early recognition of pulmonary hypertension exercise doppler echocardiography will be used in all patients. Patients with elevated pulmonary arterial pressure at rest or during exercise (estimated...
Eligibility Criteria
Inclusion
- myelodysplastic disease or myeloproliferative diseases
Exclusion
- known pulmonary hypertension
- relevant pulmonary disease
- relevant left cardiac or valvular disease
- recent major operations
- recent changes in medications
- relevant anaemia
- inability to exercise
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00909467
Start Date
April 1 2009
End Date
November 1 2011
Last Update
March 9 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz, Pulmonology
Graz, Austria, 8036